Yokoyama, Shigetoshi
Nakayama, Shun
Xu, Lei
Pilon, Aprile L.
Kimura, Shioko http://orcid.org/0000-0001-9627-6818
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (ZIABC010449, ZIABC010449, ZIABC010449, ZIABC010449)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 5 August 2020
Revised: 24 November 2020
Accepted: 28 November 2020
First Online: 15 January 2021
Conflict of interest
: A.L.P. is an employee of APCBio Innovations and has a 51% ownership interest in APCBio Innovations, which has an interest in commercializing the rhSCGB3A2. US Patent Application (No. 62/619,511) was filed for the work including those described in this study (S.K., S.Y.). S.N. and L.X. declare no conflict of interest.